The identification of Parkinson's disease subtypes using cluster analysis: A systematic review

The clinical variability between patients with Parkinson's disease (PD) may point at the existence of subtypes of the disease. Identification of subtypes is important, since a focus on homogeneous groups may enhance the chance of success of research on mechanisms of disease and may also lead to tailored treatment strategies. Cluster analysis (CA) is an objective method to classify patients into subtypes. We systematically reviewed the methodology and results of CA studies in PD to gain a better understanding of the robustness of identified subtypes. We found seven studies that fulfilled the inclusion criteria. Studies were limited by incomplete reporting and methodological limitations. Differences between studies rendered comparisons of the results difficult. However, it appeared that studies which applied a comparable design identified similar subtypes. The cluster profiles “old age‐at‐onset and rapid disease progression” and “young age‐at‐onset and slow disease progression” emerged from the majority of studies. Other cluster profiles were less consistent across studies. Future studies with a rigorous study design that is standardized with respect to the included variables, data processing, and CA technique may advance the knowledge on subtypes in PD.© 2010 Movement Disorder Society

[1]  T. Caliński,et al.  A dendrite method for cluster analysis , 1974 .

[2]  G. W. Milligan,et al.  An examination of procedures for determining the number of clusters in a data set , 1985 .

[3]  W. Gibb,et al.  The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease. , 1988, Journal of neurology, neurosurgery, and psychiatry.

[4]  A. Lees,et al.  Parkinson's Disease Society Brain Bank, London: overview and research. , 1993, Journal of neural transmission. Supplementum.

[5]  André Hardy,et al.  An examination of procedures for determining the number of clusters in a data set , 1994 .

[6]  Joseph N. Khamalah,et al.  Using Cluster Analysis for Medical Resource Decision Making , 1995, Medical decision making : an international journal of the Society for Medical Decision Making.

[7]  P. Sopp Cluster analysis. , 1996, Veterinary immunology and immunopathology.

[8]  The use of a miniature lip transducer system in the assessment of patients with Parkinsons disease , 1999 .

[9]  H. Sagar,et al.  A data‐driven approach to the study of heterogeneity in idiopathic Parkinson's disease: identification of three distinct subtypes , 1999, Movement disorders : official journal of the Movement Disorder Society.

[10]  S. Gilman,et al.  Diagnostic criteria for Parkinson disease. , 1999, Archives of neurology.

[11]  B. Everitt,et al.  Cluster Analysis: Low Temperatures and Voting in Congress , 2001 .

[12]  R. Barker,et al.  The heterogeneity of idiopathic Parkinson's disease , 2002, Journal of Neurology.

[13]  G. Polesello,et al.  Clinical predictors in Parkinson's disease , 2002, Neurological Sciences.

[14]  Douglas Steinley,et al.  Local optima in K-means clustering: what you don't know may hurt you. , 2003, Psychological methods.

[15]  M. Vidailhet [Heterogeneity of Parkinson's disease]. , 2003, Bulletin de l'Academie nationale de medecine.

[16]  W. C. Culbertson,et al.  Evidence for Impaired Encoding and Retrieval Memory Profiles in Parkinson Disease , 2004, Cognitive and behavioral neurology : official journal of the Society for Behavioral and Cognitive Neurology.

[17]  L. Defebvre,et al.  Cognitive and SPECT characteristics predict progression of Parkinson’s disease in newly diagnosed patients , 2004, Journal of Neurology.

[18]  Rui Xu,et al.  Survey of clustering algorithms , 2005, IEEE Transactions on Neural Networks.

[19]  R. Schwarz,et al.  Patterns of psychological problems in Parkinson's disease , 2005, Acta neurologica Scandinavica.

[20]  D. Aarsland,et al.  Neuropsychiatric disturbances in Parkinson's disease clusters in five groups with different prevalence of dementia , 2005, Acta psychiatrica Scandinavica.

[21]  T. Robbins,et al.  Heterogeneity of Parkinson’s disease in the early clinical stages using a data driven approach , 2005, Journal of Neurology, Neurosurgery & Psychiatry.

[22]  K. Chaudhuri,et al.  Non-motor symptoms of Parkinson's disease: diagnosis and management , 2006, The Lancet Neurology.

[23]  M Emre,et al.  Neuropsychiatric symptoms in patients with Parkinson’s disease and dementia: frequency, profile and associated care giver stress , 2006, Journal of Neurology, Neurosurgery & Psychiatry.

[24]  A. Dupuy,et al.  Critical review of published microarray studies for cancer outcome and guidelines on statistical analysis and reporting. , 2007, Journal of the National Cancer Institute.

[25]  Monica Luciana,et al.  Interval timing and Parkinson’s disease: heterogeneity in temporal performance , 2007, Experimental Brain Research.

[26]  J. Speelman,et al.  Clinical heterogeneity in newly diagnosed Parkinson’s disease , 2008, Journal of Neurology.

[27]  I. Kryspin-Exner,et al.  Long-term effects of STN DBS on mood: psychosocial profiles remain stable in a 3-year follow-up , 2008, BMC neurology.

[28]  J. Kulisevsky,et al.  Prevalence and correlates of neuropsychiatric symptoms in Parkinson's disease without dementia , 2008, Movement disorders : official journal of the Movement Disorder Society.

[29]  D. Aarsland,et al.  The association between motor subtypes and psychopathology in Parkinson's disease. , 2009, Parkinsonism & related disorders.